Chemomab Therapeutics所有資訊

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(9.99%),OrbiMed Israel GP Ltd.(9.99%)等

09/16 16:37 (美東)

Chemomab Therapeutics | SC 13G：超過5%持股股東披露文件-Sphera Funds Management Ltd.(6.56%),Sphera Global Healthcare GP Ltd.(6.56%)等

08/20 14:38 (美東)

Chemomab Therapeutics | D：發行公告

08/09 16:43 (美東)

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(16.0%),OrbiMed Israel GP Ltd.(16.0%)等

03/11 19:23 (美東)

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(18.3%),OrbiMed Israel GP Ltd.(18.3%)等

2023/11/15 16:35 (美東)

Chemomab Therapeutics | 4：持股變動聲明-董事 Darvish Nissim

2023/07/05 17:48 (美東)

Chemomab Therapeutics | 4：持股變動聲明-董事 Quigley Jill M.

2023/06/20 06:03 (美東)

Chemomab Therapeutics | 4：持股變動聲明-首席財務官 Fatal Sigal

2023/06/16 16:03 (美東)

Chemomab Therapeutics | 3：首次持股聲明-首席財務官 Fatal Sigal

2023/06/05 16:54 (美東)

Chemomab Therapeutics | 4：持股變動聲明-董事 Moses Alan Charles

2023/03/23 07:38 (美東)

Chemomab Therapeutics | 4：持股變動聲明-董事 Nicaise Claude

2023/03/23 07:36 (美東)

Chemomab Therapeutics | 4：持股變動聲明-董事 Cohen Neil Harris

2023/03/23 07:35 (美東)

Chemomab Therapeutics | 4：持股變動聲明-董事 Darvish Nissim

2023/03/23 07:33 (美東)

Chemomab Therapeutics | 4：持股變動聲明

2023/01/05 16:49 (美東)

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(19.7%),OrbiMed Israel GP Ltd.(19.7%)

2023/01/05 16:31 (美東)

Chemomab Therapeutics | 4：持股變動聲明

2023/01/05 16:01 (美東)

Chemomab Therapeutics | 4：持股變動聲明

2022/11/18 07:53 (美東)

Chemomab Therapeutics | 4：持股變動聲明

2022/11/17 16:56 (美東)

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Adi Mor(6.4%),Kobi George(6.4%)

2022/11/17 16:40 (美東)

Chemomab Therapeutics | 3：首次持股聲明-高管 Frankel Matthew Bejosa

2022/11/15 16:03 (美東)